Mereo BioPharma (MREO) Total Debt (2017 - 2023)
Mereo BioPharma (MREO) posted quarterly Total Debt of $9.8 million for Q2 2023, down 51.09% year-over-year from $20.1 million in Q2 2022, and down 24.44% quarter-over-quarter from $13.0 million in Q4 2022.
Mereo BioPharma (MREO) Total Debt (2017 - 2023) Analysis & Trends
Mereo BioPharma (MREO) has reported Total Debt for 7 consecutive years, with $9.8 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Total Debt fell 51.09% year-over-year to $9.8 million; the TTM figure through Jun 2023 stood at $9.8 million (down 51.09% YoY), while the FY2022 annual figure was $13.0 million, down 32.94% from the prior year.
- Total Debt retreated to $9.8 million in Q2 2023 per MREO's latest filing, from $13.0 million in the prior quarter.
- Across five years, Total Debt topped out at $34.5 million in Q2 2020 and bottomed at $9.8 million in Q2 2023.
- Historically, Total Debt has averaged $21.7 million across 5 years, with a median of $21.3 million in 2020.
- Annual changes were most pronounced in 2020 — Total Debt jumped 35.81% — and 2023, when it slumped 51.09%.
- Mereo BioPharma's Total Debt stood at $26.4 million in 2019, then slipped by 19.18% to $21.3 million in 2020, then dropped by 9.03% to $19.4 million in 2021, then tumbled by 32.94% to $13.0 million in 2022, then decreased by 24.44% to $9.8 million in 2023.
- Business Quant data shows MREO's Total Debt at $9.8 million in Q2 2023, $13.0 million in Q4 2022, and $20.1 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 9.34 Bn |
| 10 | Mereo BioPharma | 47.31 Mn | 47.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 9.82 Mn |
| Dec 31, 2022 | 13.00 Mn |
| Jun 30, 2022 | 20.09 Mn |
| Dec 31, 2021 | 19.39 Mn |
| Jun 30, 2021 | 25.07 Mn |
| Dec 31, 2020 | 21.31 Mn |
| Jun 30, 2020 | 34.47 Mn |
| Dec 31, 2019 | 26.37 Mn |
| Jun 30, 2019 | 25.38 Mn |
| Dec 31, 2018 | 27.65 Mn |
| Dec 31, 2017 | 27.55 Mn |